Françoise Piard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Françoise Piard has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Tournier
Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France
1 shared publication - Caroline Chapusot
Department of Pathology, Dijon University Hospital, 21000 Dijon, France
1 shared publication - Côme Lepage
CHU Dijon, Dijon, FR, France
1 shared publication - Emilie Courcet
Département de biologie et pathologie des tumeurs, service d'anatomie et cytologie pathologiques, CLCC Georges-François-Leclerc, 1, rue Professeur-Marion, 21000 Dijon, France
1 shared publication - Jean Faivre
Burgundy Digestive Cancer Registry, INSERM U866, University of Burgundy, University Hospital of Dijon, Dijon Cedex, France
1 shared publication - Laurent Martin
Department of Pathology, University Hospital of Dijon, Dijon, France
1 shared publication
Latest Publications
- Open Access
- 13 January 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 12
Why do results conflict regarding the prognostic value of the methylation status in colon cancers? the role of the preservation method
In colorectal carcinoma, extensive gene promoter hypermethylation is called the CpG island methylator phenotype (CIMP). Explaining why studies on CIMP and survival yield conflicting results is essential. Most experiments to measure DNA methylation rely on the sodium bisulfite conversion of unmethylated cytosines into uracils. No study has evaluated the performance of bisulfite conversion and methylation levels from matched cryo-preserved and Formalin-Fixed Paraffin Embedded (FFPE) samples using pyrosequencing.
- 13 January 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 12
Open AccessWhy do results conflict regarding the prognostic value of the methylation status in colon cancers? the role of the preservation method
In colorectal carcinoma, extensive gene promoter hypermethylation is called the CpG island methylator phenotype (CIMP). Explaining why studies on CIMP and survival yield conflicting results is essential. Most experiments to measure DNA methylation rely on the sodium bisulfite conversion of unmethylated cytosines into uracils. No study has evaluated the performance of bisulfite conversion and methylation levels from matched cryo-preserved and Formalin-Fixed Paraffin Embedded (FFPE) samples using pyrosequencing.